Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 6/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 6/20 | 0.46 |
| ▸ | CHRNB4 | P30926 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29162285 | 1.00 | CHRNB2 (0.46) | CHRNB2CHRNA4CHRNB4ALDH1A1SMN1; SMN2 | |
| SCHEMBL21411636 | 1.00 | CHRNB2 (0.46) | CHRNB2CHRNA4CHRNB4ALDH1A1SMN1; SMN2 | |
| SCHEMBL28915811 | 0.93 | CYP1A2 (0.47) | CHRNB2CHRNA4CHRNB4ALDH1A1CYP1A2 | |
| SCHEMBL26923153 | 0.89 | CHRNB2 (0.56) | CHRNB2CHRNA4CHRNB4ALDH1A1SMN1; SMN2 | |
| SCHEMBL12410137 | 0.79 | CHRNB2 (0.42) | CHRNB2CHRNA4CHRNB4ALDH1A1CYP1A2 | |
| SCHEMBL12410080 | 0.79 | CHRNB2 (0.42) | CHRNB2CHRNA4CHRNB4ALDH1A1CA1 | |
| SCHEMBL23804658 | 0.79 | ESRRB (0.37) | CHRNB2CHRNA4CHRNB4ALDH1A1SMN1; SMN2 | |
| SCHEMBL7712990 | 0.79 | ESRRB (0.37) | CHRNB2CHRNA4CHRNB4ALDH1A1SMN1; SMN2 | |
| SCHEMBL25184306 | 0.78 | LTA4H (0.46) | CHRNB2CHRNA4CHRNB4ALDH1A1CYP1A2 | |
| SCHEMBL23849153 | 0.78 | LTA4H (0.46) | CHRNB2CHRNA4CHRNB4ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 923 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4727996-A1 | METHOD FOR REMOVAL OF ADDITIVES FROM A POLYMERIC MATERIAL | BASF SE (DE) | 2026-04-22 | — | — | EP | claimed |
| EP-4720173-A1 | POROUS MEMBRANE, ITS METHOD OF PRODUCTION, AND AN ALKALINE ELECTROLYZER WITH SUCH MEMBRANE | Stiesdahl Hydrogen A/S (DK) | 2026-04-08 | — | — | EP | claimed |
| US-20260001275-A1 | Method for Processing Thermoset Parts | ADDITIVE MANUFACTURING TECH LTD (GB) | 2026-01-01 | — | — | US | claimed |
| WO-2025261798-A1 | PROCESS FOR THE PREPARATION OF A SULFONATED POLY(ETHER NITRILE) POLYMER (SPEN) | BASF SE (DE) | 2025-12-26 | — | — | WO | claimed |
| WO-2025261928-A1 | USE OF A MEMBRANE (M) COMPRISING A POLY(ETHER NITRILE) POLYMER (PEN) IN A MEMBRANE HUMIDIFIER (MH) FOR FUEL CELLS (FCS) | BASF SE (DE) | 2025-12-26 | — | — | WO | claimed |
| EP-4665817-A1 | IONIC LIQUIDS AND USE THEREOF FOR DISSOLVING OR PREVENTING DEPOSITS, MAINLY FORMED BY SULFUR, WHICH IMPAIR PRODUCTION OF GAS WELLS | ENI S.p.A. (IT) | 2025-12-24 | — | — | EP | claimed |
| EP-4637976-A1 | OXIDATION RESISTANT MEMBRANES | BASF SE (DE) | 2025-10-29 | — | — | EP | claimed |
| EP-4638602-A1 | POLYMERIC COMPOSITION COMPRISING A BLEND OF POLY(ARYL ETHER SULFONE) POLYMERS SUITABLE FOR MANUFACTURING ARTICLES | Syensqo Specialty Polymers USA, LLC (US) | 2025-10-29 | — | — | EP | claimed |
| EP-4633783-A1 | COMPOSITIONS FOR PREPARING MEMBRANES FROM POLYMER SOLUTIONS | The Lubrizol Corporation (US) | 2025-10-22 | — | — | EP | claimed |
| WO-2025217491-A1 | STABLE SOLUBLE LIQUID FORMULATION FOR INSECTICIDE | CORTEVA AGRISCIENCE LLC (US) | 2025-10-16 | — | — | WO | claimed |
| EP-3131989-A1 | LOW TOXICITY SOLVENT SYSTEM FOR POLYAMIDEIMIDE AND POLYAMIDE AMIC ACID RESIN COATING | Fujifilm Hunt Chemicals U.S.A., Inc. (US) | 2017-02-22 | — | — | EP | claimed |
| WO-2016108927-A2 | NITRIFICATION INHIBITOR COMPOSITIONS AND METHODS FOR PREPARING THE SAME | DOW AGROSCIENCES LLC (US) | 2016-07-07 | — | — | WO | claimed |
| US-20150299393-A1 | LOW TOXICITY SOLVENT SYSTEM FOR POLYAMDIEIMIDE AND POLYAMIDE AMIC ACID RESIN MANUFACTURE | CYMER-DAYTON, LLC | 2015-10-22 | — | — | US | claimed |
| WO-2015161131-A1 | LOW TOXICITY SOLVENT SYSTEM FOR POLYAMIDEIMIDE AND POLYAMIDE AMIC ACID RESIN COATING | FUJIFILM HUNT CHEMICALS US, INC. (US) | 2015-10-22 | — | — | WO | claimed |
| US-20150299513-A1 | LOW TOXICITY SOLVENT SYSTEM FOR POLYAMIDEIMIDE AND POLYAMIDE AMIC ACID RESIN COATING | CYMER-DAYTON, LLC | 2015-10-22 | — | — | US | claimed |
| WO-2015161107-A1 | LOW TOXICITY SOLVENT SYSTEM FOR POLYAMIDEIMIDE AND POLYAMIDE AMIC ACID RESIN MANUFACTURE | FUJIFILM HUNT CHEMICALS US, INC. (US) | 2015-10-22 | — | — | WO | claimed |
| US-20150057375-A1 | USE OF IMPROVED N-ALKYL PYRROLIDONE SOLVENT | TAMINCO (BE) | 2015-02-26 | — | — | US | claimed |
| EP-2804940-A1 | USE OF IMPROVED N-ALKYL PYRROLIDONE SOLVENTS | Taminco (BE) | 2014-11-26 | — | — | EP | claimed |
| CN-104136595-A | USE OF IMPROVED N-ALKYL PYRROLIDONE SOLVENTS | TAMINCO | 2014-11-05 | — | — | CN | claimed |
| WO-2013107822-A1 | USE OF IMPROVED N-ALKYL PYRROLIDONE SOLVENTS | TAMINCO (BE) | 2013-07-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001275-A1 | Method for Processing Thermoset Parts | TMEM63A, PARP3, GSDMD | CHRNB2 3790/4885CHRNA4 4230/4885CHRNB4 3640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.